Vaccinex
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Vaccinex's past years’ income statements indicate that its last revenue has increased compared to the previous period by 470% to $570,000. Profit margin reached -3553%. Total operating expenses were $23,455,000.
Profit Margin
| 2016 | 316K | -13.94M | -4412.34% |
|---|---|---|---|
| 2017 | 90K | -18.72M | -20802.22% |
| 2018 | 724K | -29.51M | -4077.07% |
| 2019 | 523K | -32.01M | -6121.41% |
| 2020 | 50K | -29.30M | -58618% |
| 2021 | 900K | -23.23M | -2581.33% |
| 2022 | 100K | -19.72M | -19722% |
| 2023 | 570K | -20.25M | -3552.81% |
VCNX Income Statement (2016 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||
Revenue | 570K | 100K | 900K | 50K | 523K | 724K | 90K | 316K |
Cost of revenue | 0 | 207K | 169K | 2K | 199K | 1.03M | 160K | 115K |
Gross profit | 570K | -107K | 731K | 48K | 324K | -309K | -70K | 201K |
Operating exp. | ||||||||
Research and development | 16.57M | 13.97M | 17.16M | 21.54M | 25.67M | 22.35M | 16.55M | 16.02M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 23.45M | 20.00M | 23.39M | 28.37M | 32.33M | 26.97M | 21.03M | 20.46M |
Operating income | -22.88M | -19.90M | -22.49M | -28.33M | -32.01M | -27.28M | -21.10M | -20.25M |
Other income (expenses), net | 2.63M | 91K | 110K | -520K | 152K | -1.84M | 2.34M | 9.30M |
Income before tax | -20.25M | -19.81M | -22.38M | -28.85M | -31.86M | -29.51M | -18.75M | -13.94M |
Income tax expense | 0 | -93K | 852K | 458K | 152K | -1.84M | 1.28M | 2.98M |
Net income | -20.25M | -19.72M | -23.23M | -29.30M | -32.01M | -29.51M | -18.72M | -13.94M |
Earnings per share | ||||||||
Basic EPS | -43.68 | -97.59 | -170.04 | -327.62 | -521.95 | -1.18K | -689.86 | -526.85 |
Diluted EPS | -43.68 | -97.59 | -169.11 | -327.62 | -521.95 | -1.18K | -689.86 | -526.85 |
| Data source | Data source | Data source | Data source | Data source | Data source |